The effect of oral bisphosphonates on acute kidney injury, gastrointestinal events and hypocalcaemia in patients with chronic kidney disease
Oral bisphosphonates (oBP) are contraindicated in patients with severe chronic kidney disease (CKD), but there is a lack of data on safety in this area. We aimed to study the association between oBP use and risk of acute kidney injury (AKI), gastrointestinal events (GIE) and hypocalcaemia (HC) in pa...
Main Authors: | Robinson, D, Ali, M, Pallares, N, Tebe, C, Cooper, C, Abrahamsen, B, Caskey, F, Ben-Shlomo, Y, Judge, A, Javaid, M, Diez-Perez, A, Prieto-Alhambra, D |
---|---|
פורמט: | Conference item |
יצא לאור: |
Springer London
2018
|
פריטים דומים
-
The effect of oral bisphosphonates on acute kidney injury, gastrointestinal events and hypocalcaemia in patients with chronic kidney disease
מאת: Ali, M, et al.
יצא לאור: (2018) -
Oral bisphosphonate use and risk of acute kidney injury, gastrointestinal events and hypocalcaemia in patients with moderate-advanced chronic kidney disease: a population-based cohort study
מאת: Ali, MS, et al.
יצא לאור: (2017) -
Oral bisphosphonates and chronic kidney disease: progression and safety
מאת: Prieto-Alhambra, D, et al.
יצא לאור: (2018) -
Oral bisphosphonate use and all‐cause mortality in patients with advanced (stage IIIB+) chronic kidney disease: a propensity score analysis
מאת: Alarkawi, D, et al.
יצא לאור: (2018) -
Safety of oral bisphosphonates in moderate-to-severe chronic kidney disease: a binational cohort analysis
מאת: Robinson, DE, et al.
יצא לאור: (2021)